[The drug-induced lupus syndrome]. 1988

A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
April 1974, The Medical letter on drugs and therapeutics,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
October 1974, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
January 1973, Le Journal medical libanais. The Lebanese medical journal,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
March 1984, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
February 1994, Rheumatic diseases clinics of North America,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
January 2003, Acta medica portuguesa,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
September 1988, Journal of the Tennessee Medical Association,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
April 1995, Drug safety,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
March 2015, Expert opinion on drug safety,
A I Gritsiuk, and P A Angelutsa, and A P Viktorov, and N K Kreminskaia, and M A Brizinskiĭ
December 1972, JAMA,
Copied contents to your clipboard!